Update for cord blood unit selection in hematopoietic stem cell transplantation (workshop SFGM-TC)
Bull Cancer. 2024 Mar 13:S0007-4551(24)00076-6. doi: 10.1016/j.bulcan.2024.01.009. Online ahead of print.ABSTRACTChanging practices and the limited use of cord blood units as a source of cells for allogeneic hematopoietic stem cell transplants (HSC) led us to reconsider the recommendations established in 2011 and 2012, and to propose an update incorporating recent bibliographic data. If HLA compatibility was until now established at low resolution for HLA-A and B loci, and at high resolution for HLA-DRB1, the recent papers are converging towards an increase in the level of resolution, making way for a compatibility now def...
Source: Bulletin du Cancer - March 14, 2024 Category: Cancer & Oncology Authors: Val érie Dubois Lucie Blandin Marion Duclaut Alix Duquesne Lionel Faivre Romain Ferru-Clement Jean Roy Alexandre Walencik Leonardo Magro Federico Garnier Source Type: research

National survey of Advanced Practice Nurses in oncology-haematology: Evaluation of activity and continuing education
CONCLUSION: This study highlights that the primary concern of APN-OHs is to strengthen their practical training. Medical personnel are perceived as supportive, but challenges related to working conditions and education persist. It is essential to consider these factors to support the deployment of APN-OHs across the country and improve ongoing education.PMID:38485628 | DOI:10.1016/j.bulcan.2023.12.015 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 14, 2024 Category: Cancer & Oncology Authors: Elvire Pons-Tostivint Laure De Decker Ga ëlle Haudebert Pauline Hulo Jeanne Chen Jaafar Bennouna Thierry Mira Source Type: research

Pediatric aphereses (workshop SFGM-TC)
Bull Cancer. 2024 Mar 12:S0007-4551(24)00042-0. doi: 10.1016/j.bulcan.2023.12.008. Online ahead of print.ABSTRACTPractice of pediatric aphereses - in particular when caring for low-weight children - differs from the practice of adult aphereses, since pediatric aphereses represent low numbers of procedures, which has practical implications in terms of practical training and retraining for involved healthcare personnel, as needed for habilitation and validation of ongoing competencies. A specific training is mandatory in order to ensure both the child and the staff safety during and after collection, as well as ensure high q...
Source: Bulletin du Cancer - March 13, 2024 Category: Cancer & Oncology Authors: Christian Chabannon Malek Benakli Kamelia Alexandrova Carole Coze Jean-Hughes Dalle Christine Giraud Phuong Huynh Tarik Kanouni Justyna Kanold Isabelle Lesieur Aur élie Levavasseur Ibrahim Yakoub-Agha Etienne Baudoux Source Type: research

Administration of anti-HER2 and satisfaction of patients treated for breast cancer
CONCLUSION: SC administration of anti-HER2 under the supervision of an APN has advantages for the patient, resulting in greatest satisfaction and improved patient QOL, preferably in HOD.PMID:38480056 | DOI:10.1016/j.bulcan.2024.01.006 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 13, 2024 Category: Cancer & Oncology Authors: Sol ène Pallaro Marion Bigas Sophie Leobon Kim-Arthur Baffert Cl émentine Peyramaure Laurence Dubest Laurence Venat Ga ëlle Maillan Élise Deluche Source Type: research

Prevention, diagnosis and management of osteoradionecrosis: Where do we stand?
The objective of this literature review was to provide an overview of the management of ORN and to determine the key points that would make it possible to improve patient care. The diagnosis of ORN requires to eliminate tumor recurrence then is based on clinical arguments and imaging by CT or Cone Beam evolving in a chronic mode (more than 3-6 months). The harmonization of its classifications aims to offer comprehensive and multidisciplinary care as early as possible. Primary prevention is based on pre-therapeutic oral and dental preparation, then associated with fluoroprophylaxis if salivary recovery is insufficient and r...
Source: Bulletin du Cancer - March 13, 2024 Category: Cancer & Oncology Authors: Florent Carsuzaa M élanie Dore Sabah Falek Gr égory Delpon Julien Drouet Juliette Thariat Source Type: research

Pediatric aphereses (workshop SFGM-TC)
Bull Cancer. 2024 Mar 12:S0007-4551(24)00042-0. doi: 10.1016/j.bulcan.2023.12.008. Online ahead of print.ABSTRACTPractice of pediatric aphereses - in particular when caring for low-weight children - differs from the practice of adult aphereses, since pediatric aphereses represent low numbers of procedures, which has practical implications in terms of practical training and retraining for involved healthcare personnel, as needed for habilitation and validation of ongoing competencies. A specific training is mandatory in order to ensure both the child and the staff safety during and after collection, as well as ensure high q...
Source: Bulletin du Cancer - March 13, 2024 Category: Cancer & Oncology Authors: Christian Chabannon Malek Benakli Kamelia Alexandrova Carole Coze Jean-Hughes Dalle Christine Giraud Phuong Huynh Tarik Kanouni Justyna Kanold Isabelle Lesieur Aur élie Levavasseur Ibrahim Yakoub-Agha Etienne Baudoux Source Type: research

Administration of anti-HER2 and satisfaction of patients treated for breast cancer
CONCLUSION: SC administration of anti-HER2 under the supervision of an APN has advantages for the patient, resulting in greatest satisfaction and improved patient QOL, preferably in HOD.PMID:38480056 | DOI:10.1016/j.bulcan.2024.01.006 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 13, 2024 Category: Cancer & Oncology Authors: Sol ène Pallaro Marion Bigas Sophie Leobon Kim-Arthur Baffert Cl émentine Peyramaure Laurence Dubest Laurence Venat Ga ëlle Maillan Élise Deluche Source Type: research

Prevention, diagnosis and management of osteoradionecrosis: Where do we stand?
The objective of this literature review was to provide an overview of the management of ORN and to determine the key points that would make it possible to improve patient care. The diagnosis of ORN requires to eliminate tumor recurrence then is based on clinical arguments and imaging by CT or Cone Beam evolving in a chronic mode (more than 3-6 months). The harmonization of its classifications aims to offer comprehensive and multidisciplinary care as early as possible. Primary prevention is based on pre-therapeutic oral and dental preparation, then associated with fluoroprophylaxis if salivary recovery is insufficient and r...
Source: Bulletin du Cancer - March 13, 2024 Category: Cancer & Oncology Authors: Florent Carsuzaa M élanie Dore Sabah Falek Gr égory Delpon Julien Drouet Juliette Thariat Source Type: research

Dabrafenib and trametinib-BRAF V600E mutated pediatric gliomas
Bull Cancer. 2024 Mar 11:S0007-4551(24)00073-0. doi: 10.1016/j.bulcan.2024.01.005. Online ahead of print.NO ABSTRACTPMID:38471994 | DOI:10.1016/j.bulcan.2024.01.005 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 12, 2024 Category: Cancer & Oncology Authors: Olivia Giorgis Fran çois Doz Source Type: research

Pembrolizumab in adjuvant therapy in non-small cell lung cancers
Bull Cancer. 2024 Mar 11:S0007-4551(24)00047-X. doi: 10.1016/j.bulcan.2023.12.012. Online ahead of print.NO ABSTRACTPMID:38471995 | DOI:10.1016/j.bulcan.2023.12.012 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 12, 2024 Category: Cancer & Oncology Authors: Antoine Lef èvre Claire Tissot Source Type: research

Dabrafenib and trametinib-BRAF V600E mutated pediatric gliomas
Bull Cancer. 2024 Mar 11:S0007-4551(24)00073-0. doi: 10.1016/j.bulcan.2024.01.005. Online ahead of print.NO ABSTRACTPMID:38471994 | DOI:10.1016/j.bulcan.2024.01.005 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 12, 2024 Category: Cancer & Oncology Authors: Olivia Giorgis Fran çois Doz Source Type: research

Pembrolizumab in adjuvant therapy in non-small cell lung cancers
Bull Cancer. 2024 Mar 11:S0007-4551(24)00047-X. doi: 10.1016/j.bulcan.2023.12.012. Online ahead of print.NO ABSTRACTPMID:38471995 | DOI:10.1016/j.bulcan.2023.12.012 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 12, 2024 Category: Cancer & Oncology Authors: Antoine Lef èvre Claire Tissot Source Type: research

Pembrolizumab+chemotherapy as first-line treatment in patients with HER negative advanced oesogastric adenocarcinoma
Bull Cancer. 2024 Mar 7:S0007-4551(24)00072-9. doi: 10.1016/j.bulcan.2024.01.004. Online ahead of print.NO ABSTRACTPMID:38458924 | DOI:10.1016/j.bulcan.2024.01.004 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Martin Duval Aziz Zaanan Source Type: research

Talquetamab  - multiple myeloma after at least three prior lines of therapy
Bull Cancer. 2024 Mar 7:S0007-4551(24)00049-3. doi: 10.1016/j.bulcan.2023.12.014. Online ahead of print.NO ABSTRACTPMID:38458925 | DOI:10.1016/j.bulcan.2023.12.014 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Thomas Fatrara Emilie Chalayer Source Type: research

Sacituzumab-govitecan in hormone-receptor positive/HER2-negative advanced breast cancer
Bull Cancer. 2024 Mar 7:S0007-4551(24)00046-8. doi: 10.1016/j.bulcan.2023.12.011. Online ahead of print.NO ABSTRACTPMID:38458926 | DOI:10.1016/j.bulcan.2023.12.011 (Source: Bulletin du Cancer)
Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Hanna Besnainou Luc Cabel Source Type: research